Real-world experience with venetoclax and hypomethylating agents in myelodysplastic syndromes with excess blasts.
Gangat N, McCullough K, Johnson I, Al-Kali A, Begna KH, Patnaik MM, Litzow MR, Hogan W, Shah M, Alkhateeb H, Mangaonkar A, Foran JM, Badar T, Palmer JM, Sproat L, Arana Yi CY, Pardanani A, Tefferi A.
Gangat N, et al.
Am J Hematol. 2022 Jun 1;97(6):E214-E216. doi: 10.1002/ajh.26539. Epub 2022 Mar 24.
Am J Hematol. 2022.
PMID: 35303376
Free article.
No abstract available.